Cetirizine Hydrochloride 10135-0762
Product NDC
10135-0762- Manufacturer
- Marlex Pharmaceuticals, Inc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- October 1, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA077498
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cetirizine Hydrochloride | 10 mg/1 |
Drug Class
Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Packaging Options(5)
100 TABLET in 1 BOTTLE (10135-762-01)
300 TABLET in 1 BOTTLE (10135-762-03)
500 TABLET in 1 BOTTLE (10135-762-05)
30 TABLET in 1 BOTTLE (10135-762-30)
90 TABLET in 1 BOTTLE (10135-762-90)